Articles
Simultaneous Dual Emission Detection Now Available Using BMG LABTECH's PHERAstar With Invitrogen's Adapta™ Universal Kinase Assay
March 13, 2008
BMG LABTECH and Invitrogen are co-sponsoring a tutorial at the Society for Biomolecular Sciences Annual Conference. The tutorial will take place on Monday April 7th, 2008 at the America Center in St. Louis, MO from 9:00-9:45 am in Room 232. The tutorial demonstrates the invreased effectiveness of BMG LABTECH's PHERAstar using Invitrogen's Adapta™ Universal Kinase Assay
Time resolved-fluorescence resonance energy transfer (TR-FRET) based assays using europium chelates as donor lanthanide molecules paired with red acceptor fluorophore molecules (e.g. Alexa Fluor® 647) are widely used to screen key drug targets such as kinases.
The Invitrogen Adapta™ Universal Kinase Assay is a biochemical TR-FRET assay utilizing substrate independent ADP detection ideally suited for lipid kinases. Validation of this platform technology with BMG Labtech's PHERAstar multi-detection microplate reader demonstrates compatibility with a high-end instrument amenable to high-throughput screening of difficult kinase targets.
The tutorial is free and available to attendees via required pre-registration Register for this tutorial through this link: www.bmglabtech.com/sbstutorial/sbs.cfm
SOURCE: BMG LABTECH, GmbH and Invitrogen
